Literature DB >> 22593166

Structural insight into African horsesickness virus infection.

Violeta Manole1, Pasi Laurinmäki, Wouter Van Wyngaardt, Christiaan A Potgieter, Isabella M Wright, Gert J Venter, Alberdina A van Dijk, B Trevor Sewell, Sarah J Butcher.   

Abstract

African horsesickness (AHS) is a devastating disease of horses. The disease is caused by the double-stranded RNA-containing African horsesickness virus (AHSV). Using electron cryomicroscopy and three-dimensional image reconstruction, we determined the architecture of an AHSV serotype 4 (AHSV-4) reference strain. The structure revealed triple-layered AHS virions enclosing the segmented genome and transcriptase complex. The innermost protein layer contains 120 copies of VP3, with the viral polymerase, capping enzyme, and helicase attached to the inner surface of the VP3 layer on the 5-fold axis, surrounded by double-stranded RNA. VP7 trimers form a second, T=13 layer on top of VP3. Comparative analyses of the structures of bluetongue virus and AHSV-4 confirmed that VP5 trimers form globular domains and VP2 trimers form triskelions, on the virion surface. We also identified an AHSV-7 strain with a truncated VP2 protein (AHSV-7 tVP2) which outgrows AHSV-4 in culture. Comparison of AHSV-7 tVP2 to bluetongue virus and AHSV-4 allowed mapping of two domains in AHSV-4 VP2, and one in bluetongue virus VP2, that are important in infection. We also revealed a protein plugging the 5-fold vertices in AHSV-4. These results shed light on virus-host interactions in an economically important orbivirus to help the informed design of new vaccines.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22593166      PMCID: PMC3421665          DOI: 10.1128/JVI.00517-12

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  61 in total

1.  Structure of the reovirus core at 3.6 A resolution.

Authors:  K M Reinisch; M L Nibert; S C Harrison
Journal:  Nature       Date:  2000-04-27       Impact factor: 49.962

2.  Bsoft: image and molecular processing in electron microscopy.

Authors:  J B Heymann
Journal:  J Struct Biol       Date:  2001 Feb-Mar       Impact factor: 2.867

3.  Translocation portals for the substrates and products of a viral transcription complex: the bluetongue virus core.

Authors:  J M Diprose; J N Burroughs; G C Sutton; A Goldsmith; P Gouet; R Malby; I Overton; S Ziéntara; P P Mertens; D I Stuart; J M Grimes
Journal:  EMBO J       Date:  2001-12-17       Impact factor: 11.598

4.  Expression and functional characterization of bluetongue virus VP2 protein: role in cell entry.

Authors:  S S Hassan; P Roy
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

5.  Expression and functional characterization of bluetongue virus VP5 protein: role in cellular permeabilization.

Authors:  S H Hassan; C Wirblich; M Forzan; P Roy
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

6.  Identification of antigenic regions on VP2 of African horsesickness virus serotype 3 by using phage-displayed epitope libraries.

Authors:  L Bentley; J Fehrsen; F Jordaan; H Huismans; D H du Plessis
Journal:  J Gen Virol       Date:  2000-04       Impact factor: 3.891

Review 7.  Culicoides biting midges: their role as arbovirus vectors.

Authors:  P S Mellor; J Boorman; M Baylis
Journal:  Annu Rev Entomol       Date:  2000       Impact factor: 19.686

8.  Structure of bluetongue virus particles by cryoelectron microscopy.

Authors:  E A Hewat; T F Booth; P Roy
Journal:  J Struct Biol       Date:  1992 Jul-Aug       Impact factor: 2.867

9.  Bluetongue virus entry into cells.

Authors:  Mario Forzan; Mark Marsh; Polly Roy
Journal:  J Virol       Date:  2007-01-31       Impact factor: 5.103

10.  Saliva proteins of vector Culicoides modify structure and infectivity of bluetongue virus particles.

Authors:  Karin E Darpel; Kathrin F A Langner; Manfred Nimtz; Simon J Anthony; Joe Brownlie; Haru-Hisa Takamatsu; Philip S Mellor; Peter P C Mertens
Journal:  PLoS One       Date:  2011-03-14       Impact factor: 3.240

View more
  19 in total

1.  Trafficking of bluetongue virus visualized by recovery of tetracysteine-tagged virion particles.

Authors:  Junzheng Du; Bishnupriya Bhattacharya; Theresa H Ward; Polly Roy
Journal:  J Virol       Date:  2014-08-20       Impact factor: 5.103

2.  Structural Protein VP2 of African Horse Sickness Virus Is Not Essential for Virus Replication In Vitro.

Authors:  René G P van Gennip; Sandra G P van de Water; Christiaan A Potgieter; Piet A van Rijn
Journal:  J Virol       Date:  2017-01-31       Impact factor: 5.103

3.  A correlation between capsid protein VP2 and the plaque morphology of African horse sickness virus in cell culture.

Authors:  Mathilde L Schade-Weskott; Antoinette van Schalkwyk; J J O Koekemoer
Journal:  Virus Genes       Date:  2018-05-05       Impact factor: 2.332

4.  VP2 Exchange and NS3/NS3a Deletion in African Horse Sickness Virus (AHSV) in Development of Disabled Infectious Single Animal Vaccine Candidates for AHSV.

Authors:  Sandra G P van de Water; René G P van Gennip; Christiaan A Potgieter; Isabel M Wright; Piet A van Rijn
Journal:  J Virol       Date:  2015-06-10       Impact factor: 5.103

5.  Assembly of Replication-Incompetent African Horse Sickness Virus Particles: Rational Design of Vaccines for All Serotypes.

Authors:  Valeria Lulla; Aleksei Lulla; Kerstin Wernike; Andrea Aebischer; Martin Beer; Polly Roy
Journal:  J Virol       Date:  2016-07-27       Impact factor: 5.103

6.  Protective efficacy of multivalent replication-abortive vaccine strains in horses against African horse sickness virus challenge.

Authors:  Valeria Lulla; Andres Losada; Sylvie Lecollinet; Adeline Kerviel; Thomas Lilin; Corinne Sailleau; Cecile Beck; Stephan Zientara; Polly Roy
Journal:  Vaccine       Date:  2017-06-29       Impact factor: 3.641

7.  Characterising Non-Structural Protein NS4 of African Horse Sickness Virus.

Authors:  Lizahn Zwart; Christiaan A Potgieter; Sarah J Clift; Vida van Staden
Journal:  PLoS One       Date:  2015-04-27       Impact factor: 3.240

8.  Ns1 is a key protein in the vaccine composition to protect Ifnar(-/-) mice against infection with multiple serotypes of African horse sickness virus.

Authors:  Francisco de la Poza; Eva Calvo-Pinilla; Elena López-Gil; Alejandro Marín-López; Francisco Mateos; Javier Castillo-Olivares; Gema Lorenzo; Javier Ortego
Journal:  PLoS One       Date:  2013-07-23       Impact factor: 3.240

9.  Full-genome characterisation of Orungo, Lebombo and Changuinola viruses provides evidence for co-evolution of orbiviruses with their arthropod vectors.

Authors:  Fauziah Mohd Jaafar; Mourad Belhouchet; Manjunatha Belaganahalli; Robert B Tesh; Peter P C Mertens; Houssam Attoui
Journal:  PLoS One       Date:  2014-01-24       Impact factor: 3.240

10.  Complete Genome Sequences of Four African Horse Sickness Virus Strains from a Commercial Tetravalent Live Attenuated Vaccine.

Authors:  Alan J Guthrie; Peter Coetzee; Darren P Martin; Carina W Lourens; Estelle H Venter; Camilla T Weyer; Christopher Joone; Misha le Grange; Cindy K Harper; Peter G Howell; N James MacLachlan
Journal:  Genome Announc       Date:  2015-11-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.